Today, the simultaneous analysis of this panel—comprising autoantibodies to insulin, GAD65, IA-2, and ZnT8—constitutes the gold standard for serological diagnosis, providing optimal sensitivity and specificity for confirming the autoimmune etiology of T1D and for assessing disease risk [35]. This evidence concerns the gene SLC30A8 and type 1 diabetes mellitus.